
PF-06648671
CAS No. 1587727-31-8
PF-06648671( PF6648671 )
Catalog No. M12266 CAS No. 1587727-31-8
PF-06648671 (PF6648671) is a novel oral γ-secretase modulator being developed for the treatment of Alzheimer's disease.
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
5MG | 896 | In Stock |
![]() ![]() |
50MG | 3222 | In Stock |
![]() ![]() |
100MG | 4410 | In Stock |
![]() ![]() |
200MG | Get Quote | In Stock |
![]() ![]() |
500MG | Get Quote | In Stock |
![]() ![]() |
1G | Get Quote | In Stock |
![]() ![]() |
Biological Information
-
Product NamePF-06648671
-
NoteResearch use only, not for human use.
-
Brief DescriptionPF-06648671 (PF6648671) is a novel oral γ-secretase modulator being developed for the treatment of Alzheimer's disease.
-
DescriptionPF-06648671 (PF6648671) is a novel oral γ-secretase modulator being developed for the treatment of Alzheimer's disease.Alzheimer Disease Phase 1 Discontinued.
-
In VitroIn a cell-based assay, PF-06648671 reduces Aβ42 and Aβ40 , with concomitant increases in Aβ37 and Aβ38, without inhibiting the cleavage of Notch or other substrates.
-
In VivoPF-06648671 demonstrates reduces Aβ42 within the brain and CSF following acute oral administration in animals.
-
SynonymsPF6648671
-
PathwayWnt/Notch/Hedgehog
-
Targetγ-secretase
-
Recptorγ-secretase
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1587727-31-8
-
Formula Weight538.928
-
Molecular FormulaC25H23ClF4N4O3
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESO=C1C(N2CCN1[C@H]([C@H]3O[C@@H](C4=CC(F)=C(Cl)C=C4C(F)(F)F)CC3)C)=CC=C(N5C=C(C)N=C5)C2=O
-
Chemical Name2H-Pyrido[1,2-a]pyrazine-1,6-dione, 2-[(1S)-1-[(2S,5R)-5-[4-chloro-5-fluoro-2-(trifluoromethyl)phenyl]tetrahydro-2-furanyl]ethyl]-3,4-dihydro-7-(4-methyl-1H-imidazol-1-yl)-
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog



related products
-
RO4929097
RO4929097 (RG 4733) is a potent, selective, orally active γ-secretase inhibitor with IC50 of 4 nM.
-
BMS-708163
A potent, selective and orally bioavailable inhibitor of γ-secretase with Aβ40 IC50 of 3.0 nM.
-
MRK-003
A potent γ-secretase inhibitor with IC50 of 0.4 nM, inhibition of Aβ secretion from SH-SY5Y SPA4CT cells.